BioAtla Announces $65 Million Underwritten Offering of its
SAN DIEGO, Nov. 04, 2022 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of...
Source: globenewswire.com
Page 3 - Conditionally Active Biologic News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Conditionally Active Biologic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Conditionally Active Biologic Today - Breaking & Trending Today
BIOATLA ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
/PRNewswire/ -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB)...
Source: prnewswire.com
BIOATLA APPOINTS EDWARD L. WILLIAMS TO BOARD OF DIRECTORS
SAN DIEGO, Dec. 21, 2021 /PRNewswire/ -- BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic antibody therapeutics, today... | December 21, 2021
Source: marketscreener.com
BIOATLA TO PRESENT AT 40th ANNUAL J.P. MORGAN VIRTUAL HEALTHCARE CONFERENCE
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
BioAtla Conditionally Active Biologic Antibody Design And Functionality For Cancer Treatment Described In Leading Scientific Journal Peer-Reviewed Paper
Share this article Share this article SAN DIEGO, Feb. 22, 2021 /PRNewswire/ -- BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced the publication by Proceedings of the National Academy of Sciences (PNAS) that describes the design and functionality of therapeutic antibody candidates utilizing BioAtla's proprietary CAB technology making them active only in the acidic tumor microenvironment while binding is reversibly inhibited in healthy tissue. This improved tumor targeting utiliz...
Source: prnewswire.com